EUVIMEDEUVIMED entdecken
Crossref

Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease

Laura Tapella iD, Giulia Dematteis iD, Pietro La Vitola, Susanna Leva, Elisa Tonelli, Marco Raddi, Marta Delconti iD, Letizia Dacomo, Alberto La Macchia, Elisa Murari, Maria Talmon, Justyna Malecka und 8 weitere

Glia · 2024

DOI: 10.1002/glia.24509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, 2024. Verfasst von Laura Tapella und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Calcineurin, Cognitive Dysfunction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Università degli Studi del Piemonte Orientale, Fondazione CRT, Fondazione Cariplo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) represents an urgent yet unmet challenge for modern society, calling for exploration of innovative targets and therapeutic approaches. Astrocytes, main homeostatic cells in the CNS, represent promising cell‐target. Our aim was to investigate if deletion of the regulatory CaNB1 subunit of calcineurin in astrocytes could mitigate AD‐related memory deficits, neuropathology, and neuroinflammation. We have generated two, acute and chronic, AD mouse models with astrocytic CaNB1 ablation (ACN‐KO). In the former, we evaluated the ability of β‐amyloid oligomers (AβOs) to impair memory and activate glial cells once injected in the cerebral ventricle of conditional ACN‐KO mice. Next, we generated a tamoxifen‐inducible astrocyte‐specific CaNB1 knock‐out in 3xTg‐AD mice (indACNKO‐AD). CaNB1 was deleted, by tamoxifen injection, in 11.7‐month‐old 3xTg‐AD mice for 4.4 months. Spatial memory was evaluated using the Barnes maze; β‐amyloid plaques burden, neurofibrillary tangle deposition, reactive gliosis, and neuroinflammation were also assessed. The acute model showed that ICV injected AβOs in 2‐month‐old wild type mice impaired recognition memory and fostered a pro‐inflammatory microglia phenotype, whereas in ACN‐KO mice, AβOs were inactive. In indACNKO‐AD mice, 4.4 months after CaNB1 depletion, we found preservation of spatial memory and cognitive flexibility, abolishment of amyloidosis, and reduction of neurofibrillary tangles, gliosis, and neuroinflammation. Our results suggest that ACN is crucial for the development of cognitive impairment, AD neuropathology, and neuroinflammation. Astrocyte‐specific CaNB1 deletion is beneficial for both the abolishment of AβO‐mediated detrimental effects and treatment of ongoing AD‐related pathology, hence representing an intriguing target for AD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCalcineurinCognitive DysfunctionAnimalsMiceAmyloid beta-PeptidesAstrocytesDisease Models, AnimalGliosisMice, Inbred C57BLMice, TransgenicNeuroinflammatory DiseasesTamoxifenCalcium-Binding ProteinsMuscle Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseastrocytescalcineurin B1memoryneuroinflammationtherapyβ-amyloid oligomers

Substanzen

Amyloid beta-PeptidesCalcineurinTamoxifenCalcium-Binding ProteinsDSCR1 protein, mouseMuscle Proteins

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy.
  • Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.

ORCID-Profile: Laura Tapella, Giulia Dematteis, Marta Delconti, Armando A Genazzani, Claudia Balducci, Dmitry Lim

Förderung

  • Università degli Studi del Piemonte Orientale
  • Fondazione CRT
  • Fondazione Cariplo

Zitieren

APA

Tapella, L., Dematteis, G., La Vitola, P., Leva, S., Tonelli, E., Raddi, M., Delconti, M., Dacomo, L., La Macchia, A., Murari, E., Talmon, M., Malecka, J., Chrostek, G., Grilli, M., Colombo, L., Salmona, M., Forloni, G., Genazzani, A. A., Balducci, C., & Lim, D. (2024). Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease. Glia. https://doi.org/10.1002/glia.24509

Vancouver

Tapella L, Dematteis G, La Vitola P, Leva S, Tonelli E, Raddi M, et al. Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease. Glia. 2024. doi:10.1002/glia.24509

BibTeX
@article{Tapella2024,
  author = {Tapella, Laura and Dematteis, Giulia and La Vitola, Pietro and Leva, Susanna and Tonelli, Elisa and Raddi, Marco and Delconti, Marta and Dacomo, Letizia and La Macchia, Alberto and Murari, Elisa and Talmon, Maria and Malecka, Justyna and Chrostek, Gabriela and Grilli, Mariagrazia and Colombo, Laura and Salmona, Mario and Forloni, Gianluigi and Genazzani, Armando A and Balducci, Claudia and Lim, Dmitry},
  title = {Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease},
  journal = {Glia},
  year = {2024},
  doi = {10.1002/glia.24509}
}
Kostenlos starten →